Delivery Order SPE2DB24D2100-SPE2DB24FBARA
- Not listed
- This is a federal delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $11,544.06, is for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has a completion date of September 24, 2024 and is a Firm Fixed Price delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,124.82, is for the delivery of 4567666896 Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,171.84, is for the delivery of 4,568,189,942 units of the medication Losartan-HCTZ 100-25 mg tablets. The contract has a completion date of May 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the pharmaceutical product Losartan-HCTZ 100-25 mg tablets, with a ceiling value of $2,005.84 and a period of performance through March 12, 2024. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,153.53, is for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $7,106.49 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Losartan-HCTZ 100-25 mg tablets in 90-count bottles. The contract has a period of performance through June 16, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,935.62, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
- This is a $30,269.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Losartan-HCTZ 100-25 mg tablets in 90-count packages. The contract has an ultimate completion date of March 26, 2025. This delivery order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has a firm fixed price of $6,573.14 and a completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,596.20, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB24FBARADelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $40,008.09, is for the supply of Losartan-HCTZ 100-25 mg tablets in 1,000-count bottles. The contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.0k | 3/29/24 |